FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894919654> ?p ?o ?g. }

• W2894919654 abstract "To compare three initial monthly intravitreal ranibizumab (IVR) injections followed by pro re nata (PRN) dosing with one initial monthly IVR injections followed by PRN dosing for macular edema (ME) secondary to branch retinal vein occlusion (BRVO).Forty-two eyes of 42 patients who had IVR injections for BRVO were retrospectively studied. Eighteen eyes received 1 initial IVR injection (1+PRN group) and 24 eyes received 3 monthly IVR injections (3+PRN). At 1, 3, 6 and 12mo; spectral-domain optical coherence tomography (SD-OCT) was performed. Central macular thickness (CMT), the integrity of the external limiting membrane (ELM), the presence of subretinal fluid, cyst size, the presence of inner segment/outer segment (IS/OS) defect were determined.At baseline the mean CMT was 521.3±153.2 µm in the 3+PRN group while it was 438.1±162.4 µm in 1+PRN group. At the final visit, mean CMT was 278.3±87.8 µm in the 3+PRN group and 285.2±74.2 µm in the 1+PRN group (P=0.079). The changes in CMT over the entire study period were also comparable in both groups (243±160 µm in the 3+PRN group, and 152.9±175.3 µm in the 1+PRN group; P=0.090). At baseline, best-corrected visual acuity (BCVA) was 0.92±0.60 logarithm of the minimal angle of resolution (logMAR) in the 3+PRN group, while it was 0.72±0.46 logMAR in the 1+PRN group. Final BCVA was 0.42±0.55 logMAR in the 3+PRN group and 0.38±0.50 logMAR in the 1+PRN group (P=0.979). Additionally, the BCVA changes from baseline to final visit were not significantly different (-0.50±0.45 logMAR in the 3+PRN group, and -0.33±0.39 logMAR in the 1+PRN group; P=0.255).No significant differences in the anatomical or functional results are found between 3+PRN and 1+PRN regimens in the patients receiving ranibizumab for ME secondary to BRVO. Intact IS/OS and baseline BCVA are good predictor of the visual gain, while baseline CMT is a good predictor of the anatomical gain." @default.
• W2894919654 created "2018-10-12" @default.
• W2894919654 creator A5000239181 @default.
• W2894919654 creator A5036650694 @default.
• W2894919654 creator A5041254148 @default.
• W2894919654 creator A5061410198 @default.
• W2894919654 creator A5079124716 @default.
• W2894919654 creator A5088439845 @default.
• W2894919654 date "2018-09-18" @default.
• W2894919654 modified "2023-10-18" @default.
• W2894919654 title "Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion" @default.
• W2894919654 cites W1532495830 @default.
• W2894919654 cites W161240884 @default.
• W2894919654 cites W1968756919 @default.
• W2894919654 cites W1983271723 @default.
• W2894919654 cites W2025722463 @default.
• W2894919654 cites W2031246040 @default.
• W2894919654 cites W2033046224 @default.
• W2894919654 cites W2034056754 @default.
• W2894919654 cites W2052204551 @default.
• W2894919654 cites W2128701654 @default.
• W2894919654 cites W2214801776 @default.
• W2894919654 cites W2289554791 @default.
• W2894919654 cites W2315029662 @default.
• W2894919654 cites W2335369182 @default.
• W2894919654 cites W2344355756 @default.
• W2894919654 cites W2419195469 @default.
• W2894919654 cites W2503831487 @default.
• W2894919654 cites W2521335007 @default.
• W2894919654 cites W2595909248 @default.
• W2894919654 cites W2595995661 @default.
• W2894919654 cites W2608488415 @default.
• W2894919654 cites W2612868372 @default.
• W2894919654 cites W2758887335 @default.
• W2894919654 cites W2767447900 @default.
• W2894919654 doi "https://doi.org/10.18240/ijo.2018.09.17" @default.
• W2894919654 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6133896" @default.
• W2894919654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30225230" @default.
• W2894919654 hasPublicationYear "2018" @default.
• W2894919654 type Work @default.
• W2894919654 sameAs 2894919654 @default.
• W2894919654 citedByCount "4" @default.
• W2894919654 countsByYear W28949196542021 @default.
• W2894919654 countsByYear W28949196542022 @default.
• W2894919654 countsByYear W28949196542023 @default.
• W2894919654 crossrefType "journal-article" @default.
• W2894919654 hasAuthorship W2894919654A5000239181 @default.
• W2894919654 hasAuthorship W2894919654A5036650694 @default.
• W2894919654 hasAuthorship W2894919654A5041254148 @default.
• W2894919654 hasAuthorship W2894919654A5061410198 @default.
• W2894919654 hasAuthorship W2894919654A5079124716 @default.
• W2894919654 hasAuthorship W2894919654A5088439845 @default.
• W2894919654 hasBestOaLocation W28949196541 @default.
• W2894919654 hasConcept C118487528 @default.
• W2894919654 hasConcept C141071460 @default.
• W2894919654 hasConcept C2776268601 @default.
• W2894919654 hasConcept C2776694085 @default.
• W2894919654 hasConcept C2777802072 @default.
• W2894919654 hasConcept C2778024200 @default.
• W2894919654 hasConcept C2778257484 @default.
• W2894919654 hasConcept C2778818243 @default.
• W2894919654 hasConcept C2780098626 @default.
• W2894919654 hasConcept C2780261187 @default.
• W2894919654 hasConcept C2780347916 @default.
• W2894919654 hasConcept C2780699112 @default.
• W2894919654 hasConcept C2780827179 @default.
• W2894919654 hasConcept C2781100027 @default.
• W2894919654 hasConcept C71924100 @default.
• W2894919654 hasConceptScore W2894919654C118487528 @default.
• W2894919654 hasConceptScore W2894919654C141071460 @default.
• W2894919654 hasConceptScore W2894919654C2776268601 @default.
• W2894919654 hasConceptScore W2894919654C2776694085 @default.
• W2894919654 hasConceptScore W2894919654C2777802072 @default.
• W2894919654 hasConceptScore W2894919654C2778024200 @default.
• W2894919654 hasConceptScore W2894919654C2778257484 @default.
• W2894919654 hasConceptScore W2894919654C2778818243 @default.
• W2894919654 hasConceptScore W2894919654C2780098626 @default.
• W2894919654 hasConceptScore W2894919654C2780261187 @default.
• W2894919654 hasConceptScore W2894919654C2780347916 @default.
• W2894919654 hasConceptScore W2894919654C2780699112 @default.
• W2894919654 hasConceptScore W2894919654C2780827179 @default.
• W2894919654 hasConceptScore W2894919654C2781100027 @default.
• W2894919654 hasConceptScore W2894919654C71924100 @default.
• W2894919654 hasLocation W28949196541 @default.
• W2894919654 hasLocation W28949196542 @default.
• W2894919654 hasLocation W28949196543 @default.
• W2894919654 hasLocation W28949196544 @default.
• W2894919654 hasOpenAccess W2894919654 @default.
• W2894919654 hasPrimaryLocation W28949196541 @default.
• W2894919654 hasRelatedWork W1998879016 @default.
• W2894919654 hasRelatedWork W2504938482 @default.
• W2894919654 hasRelatedWork W2605640979 @default.
• W2894919654 hasRelatedWork W2894919654 @default.
• W2894919654 hasRelatedWork W2995866787 @default.
• W2894919654 hasRelatedWork W3020972066 @default.
• W2894919654 hasRelatedWork W3125129566 @default.
• W2894919654 hasRelatedWork W3199964988 @default.
• W2894919654 hasRelatedWork W4205243730 @default.
• W2894919654 hasRelatedWork W4213422356 @default.
• W2894919654 isParatext "false" @default.

• next